M&A: Page 19
-
AbbVie to buy Allergan in $63B deal
The cash-and-stock agreement, which values Allergan shares at a 45% premium to Monday's close, delivers a forceful answer to shareholder questions on AbbVie's future beyond its top-selling drug Humira.
By Ned Pagliarulo • Updated June 25, 2019 -
Hologic moves to acquire French ultrasound company
SuperSonic Imagine makes a cart-based device used for supplemental testing in women with dense breast tissue.
By Susan Kelly • June 24, 2019 -
Thermo Fisher buys mass spec software partner HighChem
HighChem, which has worked with Thermo Fisher for 20 years, lists Pfizer, Roche and Sanofi among its customers.
By Nick Paul Taylor • June 7, 2019 -
Photo by rawpixel on Unsplash
Beckman Coulter buys Cytobank to add data analysis software
The Danaher-owned company said the software will complement its flow cytometer and help manage more complex workflows.
By Nick Paul Taylor • June 5, 2019 -
Varian ups presence in India with $283M acquisition
The Palo Alto, California-based radiation oncology systems maker will acquire Cancer Treatment Services International, which operates a network of care facilities concentrated in South Asia.
By Maria Rachal • May 21, 2019 -
Medtronic finalizes Titan Spine deal
The medtech giant will gain a portfolio of titanium interbody implants, bought for an undisclosed amount.
By Maria Rachal • Updated June 27, 2019 -
Takeda sells TachoSil patch to J&J's Ethicon for $400M
TachoSil, a surgical patch to control bleeding, contributed $155 million in net sales to the Japanese drugmaker's coffers during fiscal year 2018.
By David Lim • May 9, 2019 -
Boston Scientific closes acquisition of spinal device in $465M deal
Vertiflex's decompression system, designed to reduce pain in patients with lumbar spinal stenosis, is the company's first acquisition of 2019.
By Maria Rachal • Updated June 12, 2019 -
Getty Images
FTC judge upholds unraveling of microprocessor prosthetic knee firms deal
Ottobock must sell off its recent acquisition of microprocessor prosthetic knee maker Freedom Innovations over FTC's market concentration concerns.
By Dana Elfin • Updated May 8, 2019 -
Getty Images
Boston Scientific wins FDA approval for Vici stent
The go-ahead creates competition for BD's Venovo stent, approved in March. Cook Medical and Medtronic are currently working to get their own versions to market.
By David Lim • May 6, 2019 -
Acelity (courtesy of Maggie Fairchild)
3M completes $6.7B takeout of Acelity
The deal adds new advanced wound care and specialty surgical application offerings to the Minnesota conglomerate's medical business.
By Maria Rachal • Updated Oct. 11, 2019 -
Novartis
Alcon spin-out marks step in Novartis plan to remake business
Alcon will rank as one of the largest eye care device makers globally, with more than 20,000 employees and sales totaling $7.1 billion last year.
By Ned Pagliarulo • April 9, 2019 -
J&J closes Auris Health buy, Advanced Sterilization Products divestiture
Auris' Monarch Platform adds another robotic surgery system to J&J's lineup as the medtech giant bets on digital surgery as a growth driver.
By David Lim • April 2, 2019 -
Fotolia
Q1'19 digital health investments slow, but IPOs brewing
The latest data from Rock Health shows M&A was also down, with 21 acquisitions compared to quarterly averages of 31 deals in recent years.
By Maria Rachal • April 2, 2019 -
Getty Images
Smith & Nephew picks up pressure injury prevention device
The medtech said Wednesday it completed its acquisition of Leaf Healthcare, following a two-year partnership with the wireless patient monitoring system startup.
By Maria Rachal • Updated April 17, 2019 -
Deep Dive
Private equity sees ripe opportunity in healthcare this year
Potential targets include orthopaedics, gastroenterology and urology practices and mental health and addiction services, analysts say.
By Samantha Liss • March 25, 2019 -
Stryker to spend up to $220M on rotator cuff tear tech
The Kalamazoo, Michigan-based medtech announced it has closed a deal with Israeli startup OrthoSpace, which formerly drew investment from Johnson & Johnson and Smith & Nephew.
By Maria Rachal • March 14, 2019 -
Smith & Nephew buys skin substitute maker for $660M
The company announced Wednesday it closed the acquisition of Osiris Therapeutics.
By Susan Kelly • Updated April 17, 2019 -
Getty Images
Hill-Rom strikes $180M Voalte takeover to boost connected care unit
The acquisition will give the hospital equipment maker a communications system to complement its portfolio of smart devices.
By Nick Paul Taylor • March 13, 2019 -
Edwards deepens structural heart position with new investments
Deals with Corvia Medical and Mitralign could bolster the valve specialist's structural heart treatment abilities, where the company said it intends to remain focused.
By Susan Kelly • March 12, 2019 -
Philips nabs Carestream unit to boost informatics business
The healthcare electronics company hopes the takeover will strengthen its informatics presence outside of North America.
By Nick Paul Taylor • March 8, 2019 -
Accenture to buy Irish manufacturing services firm ESP
ESP will join Accenture's digitally-focused unit and bring along its clients, which include Stryker and Boston Scientific.
By Kristin Jensen • March 7, 2019 -
Fotolia
Oral arguments in ACLA v. Azar appeal set for April 23
In a brief, HHS argued the American Clinical Laboratory Association does not have standing to bring a lawsuit over implementation of the Protecting Access to Medicare Act.
By David Lim • March 7, 2019 -
Fotolia
Pharma strikes $220M deal for pain device player Myoscience
New Jersey-based Pacira is moving into the device sector to build a portfolio of pain products capable of reducing the need for opioids.
By Nick Paul Taylor • March 6, 2019 -
Stryker buys Arrinex to expand ENT portfolio
The takeover gives Stryker's growing ENT business a chronic rhinitis device.
By Nick Paul Taylor • Feb. 26, 2019
Previous
